COMPANIES COVERED
454 Life Sciences Corporation (A Roche Company)Download FREE Report Sample
Download Free sampleNext Generation Sequencing Market contains market size and forecasts of Next Generation Sequencing in Global, including the following market information:
Global Next Generation Sequencing Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Next Generation Sequencing market was valued at 6565.1 million in 2021 and is projected to reach US$ 17820 million by 2028, at a CAGR of 15.3% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Targeted Sequencing & Resequencing Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Next Generation Sequencing include 454 Life Sciences Corporation (A Roche Company), Agilent Technologies, Biomatters, Ltd, CLC Bio, GATC biotech AG, Macrogen, BGI (Beijing Genomics Institute), Illumina and Life Technology Corporation, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Next Generation Sequencing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Next Generation Sequencing Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Next Generation Sequencing Market Segment Percentages, by Type, 2021 (%)
Targeted Sequencing & Resequencing
Whole Genome Sequencing
Whole Exome Sequencing
Global Next Generation Sequencing Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Next Generation Sequencing Market Segment Percentages, by Application, 2021 (%)
Whole-genome Sequencing
Exome Sequencing
Targeted Resequencing
De Novo Sequencing
RNA Sequencing
ChIP Sequencing
Methyl Sequencing
Others
Global Next Generation Sequencing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Next Generation Sequencing Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Next Generation Sequencing revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Next Generation Sequencing revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
454 Life Sciences Corporation (A Roche Company)
Agilent Technologies
Biomatters, Ltd
CLC Bio
GATC biotech AG
Macrogen
BGI (Beijing Genomics Institute)
Illumina
Life Technology Corporation
EMC Corporation
Dnastar
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
